Congress created the 340B Drug Pricing Program in 1992 to protect safety-net hospitals from escalating drug prices by allowing them to purchase outpatient drugs at a discount from manufacturers. The program provides communities with access to life-saving services at no cost to taxpayers because the financial support comes from manufacturer discounts. Hospitals often use the savings they receive to provide services to low-income and uninsured patients.
This webinar will provide a brief and broad overview of the program. Then, AAMC colleagues will offer their perspectives on several areas, including an update on where things stand at the federal level; recent lawsuits; contract pharmacy issues; and other current topics of interest.
Speakers
Ivy Baer
Senior Director, Regulatory and Policy
AAMC
Jason Kleinman
Senior Legislative Analyst
AAMC
Mary Mullaney
Program Administrator, Strategy, Director, Hospital Payment Policies
AAMC